Skip to content

Clinical trials

Phase 3 Bacterial Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacterial Infections Phase: Phase 3 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20061
20073
20111
20121
20132
20144
20151
20161
20171
20191
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Melinta Therapeutics, Inc.3
Bayer2
Children's Oncology Group2
Forest Laboratories2
National Institute of Allergy and Infectious Diseases (NIAID)2
Paratek Pharmaceuticals Inc2
Pfizer2
AbbVie1
Angiotech Pharmaceuticals1
Baxis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacterial Infections24
Cellulitis5
Infections5
Skin Diseases, Bacterial4
Soft Tissue Infections4
Staphylococcal Skin Infections3
Surgical Wound Infection3
Abscess2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Staphylococcal Infections2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.